More Aurobindo Pharma Ltd news
Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Nov 05 2025

Nov 5, 2025 at 8:02 PM EST · Issued by Aurobindo Pharma Ltd

Filed with NSE · Nov 5, 2025 at 8:02 PM EST

On 6ix: 6ix.com/news/press-release-nov-05-2025-3

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Press Release".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

In the deck

  • Aurobindo Pharma — Q2 FY2026 Earnings Presentation23 slidesNov 5, 2025

Earlier from Aurobindo Pharma

  • Press Release Aug 04 2025Aug 4, 2025
  • Press Release May 26 2025May 26, 2025
  • Press Release May 13 2025May 13, 2025
  • Press Release Apr 26 2025Apr 26, 2025
  • Press Release Apr 23 2025Apr 23, 2025

Later from Aurobindo Pharma

  • Kargo.ai Raises $42M Series B to Scale Global Warehouse Deployment with Enterprise ClientsDec 22, 2025
  • Press Release Feb 09 2026Feb 9
  • Press Release Feb 13 2026Feb 13
  • Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040Feb 17
  • Press Release Feb 26 2026Feb 26
All Aurobindo Pharma news releases↗

Follow Aurobindo Pharma into a list and get an email when it puts out news.

Follow Aurobindo Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer